Is Ozempic a Peptide? What Semaglutide and Tirzepatide Are Made Of

Yes. Ozempic is a peptide drug: its active ingredient, semaglutide, is a chain of amino acids built on human GLP‑1, and the label says its “peptide backbone is produced by yeast fermentation.”^[1] Tirzepatide, the drug in Mounjaro and Zepbound, is a peptide too, 39 amino acids long.^[10] Liraglutide (Saxenda, Victoza) is another.^[6] The exception is orforglipron, sold as Foundayo: it is a small molecule, not a peptide.^[7][12] Being a peptide explains three practical things about these drugs: why they are injected, why FDA regulates them as ordinary drugs rather than biologics, and why a vial labeled “semaglutide peptide” is not Ozempic.

The short answer, drug by drug

Chemically, a peptide is a string of amino acids too short to count as a protein. All three peptide drugs above copy a gut hormone closely enough to switch on its receptor, then change a few links so the body cannot break them down in minutes. Orforglipron reaches the same GLP‑1 receptor with a completely different kind of molecule.^[12]

What semaglutide is made of

Semaglutide starts as human GLP‑1. Novo Nordisk’s chemists reported that its unmodified chain folds into the same structure as native GLP‑1(7–37),^[9] the active form of the hormone, which runs from position 7 to position 37: 31 amino acids. The FDA label describes the three changes made to that chain:^[1]

• Position 8. Modified to protect the chain from DPP‑4, the enzyme that destroys natural GLP‑1. The developers’ paper names the replacement: Aib, aminoisobutyric acid,^[8] an amino acid found in nature but not made by people.^[9]
• Position 26. The lysine here carries a hydrophilic spacer and an 18-carbon fatty di-acid. That fatty tail makes semaglutide bind to albumin, the main protein in blood, which is what stretches its half-life to about a week.^[1]
• Position 34. A small swap (to arginine) so only one fatty tail can attach.^[1][8]

The result is 94% identical in sequence to human GLP‑1.^[1] Its formula is C₁₈₇H₂₉₁N₄₅O₅₉. At 4,113.58 g/mol it is more than four times the mass of the orforglipron molecule.^[1][7] Wegovy and Rybelsus contain the same molecule; the labels repeat the description word for word.^[2][3] Because it is a peptide, the body clears it the way it clears dietary protein and fat: the label says it is broken down by cutting the peptide backbone and by burning off the fatty side chain.^[1]

Is tirzepatide a peptide?

Yes. Lilly’s first full description of the compound, then coded LY3298176, calls it “a 39 amino acid linear peptide conjugated to a C20 fatty diacid moiety.”^[10] The Mounjaro and Zepbound labels give the same structure in regulatory language: it “is based on the GIP sequence,” with Aib at positions 2 and 13, an amidated end, and a lysine at position 20 linked to a 20-carbon diacid.^[4][5]

The difference from semaglutide is the starting hormone. Semaglutide is GLP‑1 with edits. Tirzepatide is built on GIP, a second gut hormone, and tuned so that one chain switches on both the GIP and GLP‑1 receptors.^[4] The fatty tail does the same job: the label says the C20 diacid “enables albumin binding and prolongs the half-life,” about five days.^[4] Mounjaro and Zepbound are the same molecule under two brand names; the ingredient lists are identical.^[4][5]

Liraglutide, the older daily drug, is the simplest of the three. Saxenda’s label says its precursor peptide is made by yeast carrying recombinant DNA, is 97% identical to human GLP‑1 after one substitution at position 34, and carries a 16-carbon fatty acid on lysine 26.^[6] With a weaker hold on albumin, its half-life is about 13 hours, which is why it is injected every day rather than once a week.^[6]

Why being a peptide means a needle

Peptides are food to the digestive system. A Novo Nordisk absorption study put it plainly: swallowed peptide drugs are held back by “poor absorption across the gastrointestinal barrier and extensive degradation by proteolytic enzymes.”^[11] Unmodified GLP‑1 does not even survive in blood: the Saxenda label puts its half-life at 1.5 to 2 minutes.^[6] An injection under the skin skips the gut. The labels give the share of each dose that reaches the bloodstream that way:

Each figure is from that product’s label: Ozempic,^[1] Mounjaro,^[4] Saxenda,^[6] Rybelsus and the Ozempic tablets,^[3] Wegovy^[2] and Foundayo.^[7] A semaglutide tablet loses 98 to more than 99 of every 100 parts of its dose on the way in; orforglipron, which is not a peptide, keeps most of it.

How the semaglutide pills work at all: SNAC

The tablets carry a helper. Every semaglutide tablet, sold as Rybelsus, as the Wegovy pill or as Ozempic tablets, lists salcaprozate sodium (SNAC) as an inactive ingredient, and the label calls it “an absorption enhancer.”^[3][2] Novo Nordisk’s study found the peptide is absorbed in the stomach, right next to the dissolving tablet, and only when SNAC is in it: SNAC “protects against enzymatic degradation via local buffering actions and only transiently enhances absorption.”^[11]

That is why the pills come with rules. Per the Rybelsus label, a tablet goes down first thing, before food, with up to 4 ounces of water and no other liquid, and breakfast waits.^[3] Food and extra liquid get in the way of a process that already admits at most 2% of the dose. Foundayo has no SNAC and no such rule: its label says to take it “with or without food.”^[7]

Why FDA treats them as drugs, not biologics

Size decides it. Federal regulation defines a protein as “any alpha amino acid polymer with a specific, defined sequence that is greater than 40 amino acids in size,” and proteins are regulated as biological products.^[13] FDA wrote that bright line into the rules in a 2020 final rule, effective March 23, 2020, to settle “whether certain products are regulated as drugs or biological products.”^[14] A chain of 40 amino acids or fewer is a peptide, and it stays on the drug side.

• Semaglutide, 31 and tirzepatide, 39. Both are under the line. Each one is approved under a new drug application (NDA), the same pathway as a blood-pressure pill: Ozempic,^[1] Wegovy,^[2] Rybelsus,^[3] Mounjaro,^[4] Zepbound^[5] and Saxenda.^[6]
• Insulin is over it. FDA’s rule counts insulin’s two chains together, 21 plus 30 amino acids, which makes it a protein.^[14] On March 23, 2020, FDA converted the insulin approvals, from insulin aspart to insulin glargine, into biologics licenses.^[15]
• The combination pens show the line exactly. Xultophy, which pairs insulin degludec with liraglutide, and Soliqua, insulin glargine with lixisenatide, were moved to biologics licenses because of the insulin. Liraglutide alone was not.^[15]

Which side of the line a drug falls on has practical effects. A copy of a drug approved under an NDA goes through the generic route, an abbreviated new drug application, and FDA has issued guidance on when a synthetic peptide copying a yeast-made one can take that route.^[16] Which peptides a pharmacy may compound, and which approved peptides lost that route when they became biologics, is a separate question, covered in are peptides legal.

What else is in an Ozempic pen

The pen holds a clear solution, mostly water. The Ozempic label lists everything else in each milliliter:^[1]

The lists are copied from the Ozempic,^[1] Wegovy,^[2] Mounjaro,^[4] Zepbound^[5] and Rybelsus^[3] labels. Two patterns stand out. Phenol appears only in the pens that hold several doses: the Ozempic pen, the Wegovy FlexTouch and the tirzepatide KwikPen, which also adds benzyl alcohol. The single-dose Wegovy and Mounjaro pens list nothing beyond salt, a phosphate and water.^[1][2][4] And none of these products contains B12, glycine, L-carnitine or any other added active ingredient. Anything with those added is a compounded preparation; what is in a compounded GLP-1 vial explains how to read its label.

The molecule matters too. FDA has warned that some compounders used semaglutide sodium or semaglutide acetate, salts that it calls “different active ingredients than are used in the approved drugs.”^[17] The approved products use the base molecule described above. The difference is laid out in compounded vs. brand semaglutide.

Why “semaglutide peptide” for sale online is a different thing

Because semaglutide and tirzepatide are peptides, they are sold alongside BPC-157 and other research peptides as lyophilized powder, labeled “for research use only.” Chemically, the label may name the same chain. Legally and practically, it is not the drug. FDA says it has sent warnings to companies selling semaglutide, tirzepatide, retatrutide, survodutide and mazdutide under false research labels while shipping them to consumers with doses to take, and it “urges consumers not to purchase these products which are of unknown quality and may be harmful to their health.”^[17]

The approved pen comes with a reviewed formula, a stated quantity and a sterile manufacturing process. A research vial comes with a seller’s PDF. What that PDF can and cannot show is covered in how to read a peptide certificate of analysis, and what the research label means for the buyer is in buying tirzepatide as a research chemical. The wider peptide market, with the evidence for each compound, is on peptides.

A compounded prescription sits between the two. It is not the approved pen, but it is not a research vial either, because a clinician has to write it, and how that step works varies by seller. At Vaylen, clinicians from MDI Medical Group prescribe and nothing is charged until one approves you; it also sells compounded semaglutide as a tablet. At CoreAge Rx you pay before a doctor reviews the case, and the sale is final once it reaches the pharmacy. MD Total Wellness, a physician-owned clinic in Brea, California, sees patients in person and dispenses from its office the same day.

At Clinic Secret, which sells compounded semaglutide and tirzepatide, you fill in a written medical assessment and a US doctor reviews it within 24 hours, often without a call.

Pricing and disclosure differ too. Citizen Meds sells monthly kits that rise in price with the dose and publishes no pharmacy name, while Injectco, a Texas medspa chain, says its medication comes from a 503B pharmacy it does not name. Queen RX sells one-time three-month packs with the doctor consult included, and Freya Meds sells only GLP-1 care, with unlimited doctor consultations. At the far end, Shape Vantage sells a tirzepatide kit through a direct checkout link with no medical intake, and its terms make provider review something that happens only where required.

Orforglipron: the GLP-1 that is not a peptide

Foundayo’s label gives its active ingredient as orforglipron calcium, formula C₄₈H₄₇F₂N₁₀O₅ with half a calcium atom, molecular weight 902.0.^[7] No amino-acid chain appears in it. Lilly’s phase 2 trial report calls it “the nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron.”^[12] That is why it survives the stomach without a helper and can be taken with food.^[7]

Being a small molecule has a cost the peptides avoid. Orforglipron is processed by the liver enzyme CYP3A4, so the Foundayo label requires dose changes alongside some medicines that block or speed up that enzyme.^[7] Semaglutide and tirzepatide are broken down like dietary protein, by cutting the chain.^[1][4] Everything else about the pill, including results and cost, is on Foundayo (orforglipron). The full list of GLP-1 drugs is on the GLP-1 hub.